Steele Glenn JR Md Phd Insider Trades & Stock Holdings

Director · PTC Therapeutics, Inc. · Latest filing Sep 30, 2026

Steele Glenn JR Md Phd, Director at PTC Therapeutics, Inc. has 1 Form 4 trade on file since Sep 30, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($781.92K), net -$781.92K. Latest filing: disposed of 12K shares of $PTCT on Sep 30, 2026 at $65.16.

Trades on file

1

Open-market bought

$0

Open-market sold

$781.92K

Net open-market

-$781.92K

Latest filing

Sep 30, 2026

All insider trades by Steele Glenn JR Md Phd

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 30, 2026	$PTCT	Sell (Open-market sale) 10b5-1	12K	$65.16	$781.92K			-2.4%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Steele Glenn JR Md Phd traded

• $PTCT

Frequently asked questions

Has Steele Glenn JR Md Phd been buying or selling stock?

Steele Glenn JR Md Phd has 0 open-market purchases and 1 open-market sale on file, net -$781.92K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Steele Glenn JR Md Phd's latest insider trade?

disposed of 12K shares of $PTCT on Sep 30, 2026 at $65.16.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.